21
Jul
Prescription-strength fluoride products, commonly used to prevent tooth decay in patients at high risk, are now under regulatory review by the U.S. Food and Drug Administration (FDA). Despite decades of use and support from dental professionals, the FDA has begun re-examining these fluoride formulations due to technicalities in how they are classified and approved—raising concerns among healthcare providers and advocates about the future availability of an essential tool in oral health care.For many dental experts, prescription fluoride has long been a critical part of treatment for individuals vulnerable to cavities, including children, older adults, and patients with medical conditions that…
